159 related articles for article (PubMed ID: 20618968)
1. The impact of bisphosphonates on the osteoblast proliferation and Collagen gene expression in vitro.
Koch FP; Yekta SS; Merkel C; Ziebart T; Smeets R
Head Face Med; 2010 Jul; 6():12. PubMed ID: 20618968
[TBL] [Abstract][Full Text] [Related]
2. Zoledronate, ibandronate and clodronate enhance osteoblast differentiation in a dose dependent manner--a quantitative in vitro gene expression analysis of Dlx5, Runx2, OCN, MSX1 and MSX2.
Koch FP; Merkel C; Al-Nawas B; Smeets R; Ziebart T; Walter C; Wagner W
J Craniomaxillofac Surg; 2011 Dec; 39(8):562-9. PubMed ID: 21030265
[TBL] [Abstract][Full Text] [Related]
3. Influence of bisphosphonates on the osteoblast RANKL and OPG gene expression in vitro.
Koch FP; Merkel C; Ziebart T; Smeets R; Walter C; Al-Nawas B
Clin Oral Investig; 2012 Feb; 16(1):79-86. PubMed ID: 20938793
[TBL] [Abstract][Full Text] [Related]
4. The influence of bisphosphonates on human osteoblast migration and integrin aVb3/tenascin C gene expression in vitro.
Koch FP; Wunsch A; Merkel C; Ziebart T; Pabst A; Yekta SS; Blessmann M; Smeets R
Head Face Med; 2011 Feb; 7(1):4. PubMed ID: 21299894
[TBL] [Abstract][Full Text] [Related]
5. Bisphosphonate Modulation of the Gene Expression of Different Markers Involved in Osteoblast Physiology: Possible Implications in Bisphosphonate-Related Osteonecrosis of the Jaw.
Manzano-Moreno FJ; Ramos-Torrecillas J; Melguizo-Rodríguez L; Illescas-Montes R; Ruiz C; García-Martínez O
Int J Med Sci; 2018; 15(4):359-367. PubMed ID: 29511371
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of osteoblast function in vitro by aminobisphosphonates.
Orriss IR; Key ML; Colston KW; Arnett TR
J Cell Biochem; 2009 Jan; 106(1):109-18. PubMed ID: 19003973
[TBL] [Abstract][Full Text] [Related]
7. Bisphosphonates directly regulate cell proliferation, differentiation, and gene expression in human osteoblasts.
Reinholz GG; Getz B; Pederson L; Sanders ES; Subramaniam M; Ingle JN; Spelsberg TC
Cancer Res; 2000 Nov; 60(21):6001-7. PubMed ID: 11085520
[TBL] [Abstract][Full Text] [Related]
8. Bisphosphonates affect migration ability and cell viability of HUVEC, fibroblasts and osteoblasts in vitro.
Walter C; Pabst A; Ziebart T; Klein M; Al-Nawas B
Oral Dis; 2011 Mar; 17(2):194-9. PubMed ID: 20796232
[TBL] [Abstract][Full Text] [Related]
9. High doses of bisphosphonates reduce osteoblast-like cell proliferation by arresting the cell cycle and inducing apoptosis.
Manzano-Moreno FJ; Ramos-Torrecillas J; De Luna-Bertos E; Ruiz C; García-Martínez O
J Craniomaxillofac Surg; 2015 Apr; 43(3):396-401. PubMed ID: 25614214
[TBL] [Abstract][Full Text] [Related]
10. The influence of bisphosphonates on viability, migration, and apoptosis of human oral keratinocytes--in vitro study.
Pabst AM; Ziebart T; Koch FP; Taylor KY; Al-Nawas B; Walter C
Clin Oral Investig; 2012 Feb; 16(1):87-93. PubMed ID: 21225298
[TBL] [Abstract][Full Text] [Related]
11. Bisphosphonates influence the proliferation and the maturation of normal human osteoblasts.
Fromigué O; Body JJ
J Endocrinol Invest; 2002 Jun; 25(6):539-46. PubMed ID: 12109626
[TBL] [Abstract][Full Text] [Related]
12. In vitro comparison of clodronate, pamidronate and zoledronic acid effects on rat osteoclasts and human stem cell-derived osteoblasts.
Kellinsalmi M; Mönkkönen H; Mönkkönen J; Leskelä HV; Parikka V; Hämäläinen M; Lehenkari P
Basic Clin Pharmacol Toxicol; 2005 Dec; 97(6):382-91. PubMed ID: 16364054
[TBL] [Abstract][Full Text] [Related]
13. The effects of zoledronate on the survival and function of human osteoblast-like cells.
Huang KC; Cheng CC; Chuang PY; Yang TY
BMC Musculoskelet Disord; 2015 Nov; 16():355. PubMed ID: 26572124
[TBL] [Abstract][Full Text] [Related]
14. Zoledronic acid at subtoxic dose extends osteoblastic stage span of primary human osteoblasts.
Zara S; De Colli M; di Giacomo V; Zizzari VL; Di Nisio C; Di Tore U; Salini V; Gallorini M; Tetè S; Cataldi A
Clin Oral Investig; 2015 Apr; 19(3):601-11. PubMed ID: 25055744
[TBL] [Abstract][Full Text] [Related]
15. Exposing human epithelial cells to zoledronic acid can mediate osteonecrosis of jaw: an in vitro model.
Saracino S; Canuto RA; Maggiora M; Oraldi M; Scoletta M; Ciuffreda L; Vandone AM; Carossa S; Mozzati M; Muzio G
J Oral Pathol Med; 2012 Nov; 41(10):788-92. PubMed ID: 22650360
[TBL] [Abstract][Full Text] [Related]
16. Aminobisphosphonates cause osteoblast apoptosis and inhibit bone nodule formation in vitro.
Idris AI; Rojas J; Greig IR; Van't Hof RJ; Ralston SH
Calcif Tissue Int; 2008 Mar; 82(3):191-201. PubMed ID: 18259679
[TBL] [Abstract][Full Text] [Related]
17. Effects of two novel bisphosphonates on bone cells in vitro.
Evans CE; Braidman IP
Bone Miner; 1994 Aug; 26(2):95-107. PubMed ID: 7994190
[TBL] [Abstract][Full Text] [Related]
18. The effect of nitrogen containing bisphosphonates, zoledronate and alendronate, on the production of pro-angiogenic factors by osteoblastic cells.
Ishtiaq S; Edwards S; Sankaralingam A; Evans BA; Elford C; Frost ML; Fogelman I; Hampson G
Cytokine; 2015 Feb; 71(2):154-60. PubMed ID: 25461393
[TBL] [Abstract][Full Text] [Related]
19. Dose-dependent metabolic effect of zoledronate on primary human osteoblastic cell cultures.
Corrado A; Neve A; Maruotti N; Gaudio A; Marucci A; Cantatore FP
Clin Exp Rheumatol; 2010; 28(6):873-9. PubMed ID: 21205463
[TBL] [Abstract][Full Text] [Related]
20. Effects of bisphosphonates on proliferation and osteoblast differentiation of human bone marrow stromal cells.
von Knoch F; Jaquiery C; Kowalsky M; Schaeren S; Alabre C; Martin I; Rubash HE; Shanbhag AS
Biomaterials; 2005 Dec; 26(34):6941-9. PubMed ID: 16009417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
